Confo Therapeutics N.V. – Trademark Portfolio
Entity Type: 98
Confo Therapeutics N.V. holds 10 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 9 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 4 Nice Classification classes. Currently, 9 trademarks are registered. Notable registered marks include CONFO, CONFOGEN, MULTIGEN, CONFOBODY, and CONFOCHIMER.
Technologiepark,
Zwijnaarde 30 Gent B-9052
Showing of trademarks Trademarks
Trademark Classifications
Confo Therapeutics N.V.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Scientific and technological services; industrial analysis and research services
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does Confo Therapeutics N.V. have?
Confo Therapeutics N.V. has 10 U.S. trademarks filed with the USPTO. Of these, 9 registered.
What trademark classes does Confo Therapeutics N.V. file in?
Confo Therapeutics N.V. files trademarks across 4 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 42 (Computer & Scientific), Class 5 (Pharmaceuticals), Class 35 (Advertising & Business). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are Confo Therapeutics N.V.'s most well-known trademarks?
Confo Therapeutics N.V.'s registered trademark portfolio includes well-known marks such as CONFO, CONFOGEN, MULTIGEN, CONFOBODY, and CONFOCHIMER. These are among 9 currently registered trademarks in the portfolio.
What is Confo Therapeutics N.V.'s trademark registration success rate?
Confo Therapeutics N.V. has a 100% trademark registration rate, with 9 out of 9 resolved applications resulting in successful registration. Currently, 0 applications are pending review.